Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/18/24 EDT
8.60quote price arrow down-0.06 (-0.69%)
Volume
2,118,054
52 week range
5.57 - 11.46
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.60
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap3.153B
  • Shares Out366.67M
  • 10 Day Average Volume4.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change7.23

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.60
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23
  • Market Cap3.153B
  • Shares Out366.67M
  • 10 Day Average Volume4.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change7.23

RATIOS/PROFITABILITY

  • EPS (TTM)-1.62
  • P/E (TTM)-5.30
  • Fwd P/E (NTM)2.19
  • EBITDA (TTM)2.863B
  • ROE (TTM)-441.96%
  • Revenue (TTM)8.757B
  • Gross Margin (TTM)70.78%
  • Net Margin (TTM)-6.98%
  • Debt To Equity (MRQ)-2,190.61%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date05/18/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
BHC
Bausch Health Companies Inc
8.60-0.06-0.69%
GUD
CPH
HLS
RX
Biosyent Inc
8.45UNCHUNCH